Title |
Modelling drug-related morbidity in Sweden using an expert panel of pharmacists’
|
---|---|
Published in |
International Journal of Clinical Pharmacy, April 2012
|
DOI | 10.1007/s11096-012-9641-3 |
Pubmed ID | |
Authors |
Hanna Gyllensten, Katja M. Hakkarainen, Anna K. Jönsson, Karolina Andersson Sundell, Staffan Hägg, Clas Rehnberg, Anders Carlsten |
Abstract |
Drug-related morbidity (DRM) is common and to some extent preventable, and associated with considerable costs in patients attending hospital. In outpatients and in the general public corresponding data are limited, but pharmacists' expert opinion has suggested high rates of DRM also in US ambulatory care. It is unknown if the results are applicable in Sweden today. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Bangladesh | 1 | 2% |
Switzerland | 1 | 2% |
Brazil | 1 | 2% |
Unknown | 39 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 6 | 14% |
Other | 5 | 12% |
Researcher | 4 | 10% |
Student > Ph. D. Student | 4 | 10% |
Student > Postgraduate | 3 | 7% |
Other | 8 | 19% |
Unknown | 12 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 26% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 24% |
Nursing and Health Professions | 3 | 7% |
Computer Science | 2 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 2% |
Other | 2 | 5% |
Unknown | 13 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2013.
All research outputs
#7,709,550
of 24,744,050 outputs
Outputs from International Journal of Clinical Pharmacy
#464
of 1,232 outputs
Outputs of similar age
#50,928
of 167,709 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#4
of 23 outputs
Altmetric has tracked 24,744,050 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,232 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,709 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.